Novel aptamer to Von Willebrand factor A1 domain (TAGX-0004) shows total inhibition of thrombus formation superior to ARC1779 and comparable to caplacizumab

Kazuya Sakai, Tatsuhiko Someya, Kaori Harada, Hideo Yagi, Taei Matsui, Masanori Matsumoto

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Novel aptamer to Von Willebrand factor A1 domain (TAGX-0004) shows total inhibition of thrombus formation superior to ARC1779 and comparable to caplacizumab'. Together they form a unique fingerprint.

Medicine & Life Sciences